Page 150 - Screening for Cervical Cancer: Systematic Evidence Review

Appendix C. Evidence Tables

Evidence Table 3B. Performance of HPV Testing for Triage (cont'd)

Source: Author, Study Design &
Year Characteristics Interventions Location & Time Period
Adam et al., June Diagnostic test evaluation HPV testing of abnormal Indigent population in Harris
71
1998 among population w/2 Paps using PCR primer County, TX
minimally abnormal Paps pair MY09/11 to identify
or 1 highly abnormal; high risk types 16, 18, 31, Time period not specified
screening for HPV and 33 and 35
type compared with
colpsocopy/histology

Pap negatives not verified,
HPV negatives verified

Manos et al., May Diagnostic test evaluation HPV testing of ASCUS Northern California HMO
68
1999 among population with ThinPrep® Pap results population
ASCUS results from using Hybrid Capture II 1995-1996
ThinPrep® Pap, screening assay
for HPV and assessment
of outcome by colposcopy

Pap negatives not verified,
HPV negatives verified

Hillemanns et al., Diagnostic test evaluation Testing of self collected Munich, Germany
72
1999 (HPV) for detection of high specimens and physician
grade lesions collected specimens for Time period not specified
HPV using Hybrid
Capture II

C-56